Medical and Pharmaceutical FDA panel to review GRAIL’s Galleri multi-cancer blood test in September The application contains results from more than 70,000 participants enrolled in the intervention arm of the NHS-Galleri trial Joseph MortonAugust 11, 2026
Medical and Pharmaceutical Sionna shares plummet after cystic fibrosis clinical trial failure The 92% plunge has been beneficial for competitor Vertex Pharma Rowan DunneAugust 11, 2026
Medical and Pharmaceutical Manitoba Lung Association and BioMark use blood biopsy to tackle radon threat They are organising a feasibility study assessing the efficacy of BioMark's blood test on those exposed to the gas Rowan DunneAugust 9, 2026
Medical and Pharmaceutical Lung cancer screening awareness remains low despite advances in early detection The 2026 Lung Health Barometer found only 33 per cent of adults knew low-dose CT screening is available for high-risk people Joseph MortonAugust 6, 2026
Medical and Pharmaceutical Amplia signs Eli Lilly collaboration for Phase 1b/2b lung cancer trial The companies have already prepared an advanced draft of the trial protocol Joseph MortonAugust 5, 2026
Medical and Pharmaceutical Median Technologies partners with Canon Medical to achieve lung cancer screening goals Their collaboration seeks to expedite deployment of Median's AI-powered nodule detection system Rowan DunneJuly 31, 2026
Medical and Pharmaceutical Stand Up To Cancer charity funds non-invasive lung cancer screening projects It will provide up to US$200K for each of the three initiatives Rowan DunneJuly 29, 2026
AI and Autonomy Tempus AI buys Personalis to strengthen AI-driven cancer monitoring platform The acquisition targets a cancer monitoring market that the companies estimate could reach USD$20 billion Joseph MortonJuly 29, 2026
Medical and Pharmaceutical Replimune tanks on FDA concerns about its skin cancer therapy Shares slid by more than 37% at the intraday low on Tuesday Rowan DunneJuly 29, 2026
AI and Autonomy TidalSense raises USD$19M to expand AI-powered COPD diagnostic platform The investment comes as Britain's healthcare system struggles to diagnose COPD quickly Joseph MortonJuly 28, 2026